Timo Soeterik

77 Impact of MRI on Risk Classification SUPPLEMENTARY TABLE S1. MRI prostate protocols used in the seven hospitals during the study period Hospital 1 2 3 4 5 6 7 Field of strength of magnet 3T 3T 3T 3T 3T 3T 3T Coils use Body coil Body coil Body coil Body coil Body coil Body-array coil Body coil Slice thickness 3mm 3mm 3mm 3mm 3mm 3mm 3mm Acquired planes for T2-weighted imaging Axial, sagittal, coronal Axial, sagittal, coronal Axial, sagittal, coronal Axial, sagittal, coronal Axial, sagittal, coronal Axial, sagittal, coronal Axial, sagittal, coronal For DWI, the b-values, image sets analyses B 50-400- 800-1400 and ADC map B 0-50- 400-800- 2000 and ADC map B 0-50- 100-200- 250-800 and ADC map B 0-50- 400-800- 1500 and ADC map B 0-50- 1000-1500 and ADC map B 0-50- 400-800- 1400 and ADC map B 0-50- 1000- 1500 and ADC map Scoring system used PI-RADS v2 PI-RADS v2 PI-RADS v2 PI-RADS v2 PI-RADS v2 PI-RADS v2 PI-RADS v2 Experience of radiologists reporting prostate MRI in the period 2->5 years >5 years 6 years 2->5 years 2-10 years 2->5 years >5 years Intravenous administration Gadolinium 1.0 mg/kg (Dotarem) Gadolinium 1.0 mg/kg (Dotarem) Gadolinium 1.0 mg/kg (Dotarem) No Gadolinium 1.0 mg/kg (Dotarem) No No 4